Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I8ZM
|
|||
Former ID |
DIB003676
|
|||
Drug Name |
CR-3294
|
|||
Indication | Diarrhea [ICD-11: ME05.1; ICD-9: 787.91] | Phase 2 | [1] | |
Company |
Rottapharm Madaus
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nitric-oxide synthase inducible (NOS2) | Target Info | Inhibitor | [1], [2] |
BioCyc | Citrulline-nitric oxide cycle | |||
KEGG Pathway | Arginine biosynthesis | |||
Arginine and proline metabolism | ||||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
HIF-1 signaling pathway | ||||
Peroxisome | ||||
Salmonella infection | ||||
Pertussis | ||||
Leishmaniasis | ||||
Chagas disease (American trypanosomiasis) | ||||
Toxoplasmosis | ||||
Amoebiasis | ||||
Tuberculosis | ||||
Pathways in cancer | ||||
Small cell lung cancer | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | IL12-mediated signaling events | |||
Alpha9 beta1 integrin signaling events | ||||
ATF-2 transcription factor network | ||||
IL23-mediated signaling events | ||||
Signaling mediated by p38-alpha and p38-beta | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | ROS production in response to bacteria | |||
Nitric oxide stimulates guanylate cyclase | ||||
WikiPathways | Type II interferon signaling (IFNG) | |||
Spinal Cord Injury | ||||
AGE/RAGE pathway | ||||
Effects of Nitric Oxide |
References | Top | |||
---|---|---|---|---|
REF 1 | Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice. Cancer Chemother Pharmacol. 2010 Oct;66(5):819-27. | |||
REF 2 | Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice. Cancer Chemother Pharmacol. 2010 October; 66(5): 819-827. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.